A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents
Nana Gletsu Miller · with Purdue University · NCT07223151
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 12–18 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 63
- US sites recruiting
- 2
- Study start
- July 25, 2025
- Record last updated
- August 6, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to test whether replacing sugary sodas with unsweetened, flavored sparkling waters can reduce added sugar intake and improve health in Black/African American and Latine adolescents with obesity who prefer sweet-tasting beverages. The main questions it aims to answer are:
- Does replacing sugary sodas with water change liking for sugary drinks, and water?
- Do shifts in liking for sweetness lead to improved diet quality and cardiometabolic health?
Researchers will compare replacing sugary sodas with one of three alternative beverages: unsweetened sparkling water, plain water, and beverages with gradually reduced sugar to determine which strategy is most effective.
Participants will
- Replace sugary sodas with study drinks for 4 weeks
- Complete taste tests to measure their liking for and sensory experience of sweetness over 8-weeks
- Provide dietary recalls, body measurements, and blood samples over 8-weeks
Being studied: Unsweetened Sparkling Water Replacement; Progressively Reduced Sugar Beverage Replacement; Plain Water Replacement
Conditions: Obesity, Adolescent; Dietary Sugars; Taste Perception; Insulin Resistance; Feeding Behavior
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adolescents ages 12 to 18 who display a "sweet-liker" pattern, characterized by a preference for higher concentrations of sugar in beverages, specifically identifying 0.3M (10.3% sucrose) or above as their most liked sample.
- Adolescents consumes sugar-sweetened soda greater than or equal to 2 times per week. Adolescents must also indicate a willingness to drink study beverages; not currently dieting/changing diet.
Exclusion Criteria
- Adolescent participant is pregnant, since pregnancy affects taste perception
- Participant is allergic or intolerant to the items we are testing.
- Adolescent with type 1 or type 2 diabetes (self-declared or detected at screening visit through fasting glucose)
- Use of GLP-1 receptor agonists intended for weight loss.
Recruiting US locations
Indiana University Hospital
Indianapolis, IN 46202
Site contact: Nana Gletsu Miller, PhD · 812-855-7643 · ngletsum@iu.edu
Purdue University
West Lafayette, IN 47907
Site contact: Cordelia Running, PhD · 765-494-2282 · crunning@purdue.edu
Study contacts (from the official record)
- Nana Gletsu Miller, PhD · +1 (812) 855-9110 · ngletsum@iu.edu
Similar studies in Indiana
All weight loss studies in Indiana →- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Pfizer
- Location
- Evansville, IN + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
AstraZeneca
- Location
- Indianapolis, IN + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Eli Lilly and Company
- Location
- Brownsburg, IN + 24 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Amgen
- Location
- Munster, IN + 136 other US sites
- Eligibility basics
- Ages 45–99